Inventor
Murielle M. VENIANT-ELLISON
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
PatentTitleYear
12,465,652Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteins202512,252,540Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)202511,739,131Growth differentiation factor 15 (GDF-15) polypeptides2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to AMGEN INC (3)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 3 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2023–2025 |